MSK Focus Viscogliosi Bros., LLC specializes in neuromusculoskeletal technologies across venture capital, private equity, and merchant banking, offering a strategic entry point for medtech innovators and established MSK firms seeking growth, partnerships, or exit options.

Global Reach With portfolio products sold in over 70 countries and a track record of more than 75 med-tech devices brought to market, VB can facilitate international distribution, regulatory navigation, and scale for foreign entrants aiming to access diverse healthcare markets.

Financial Muscle VB has generated over $1.5 billion in exit value and mobilizes its own capital into ventures, signaling strong funding capability and potential co-financing opportunities for portfolio companies or partner solutions seeking capital-backed deployments.

Strategic Partnerships The firm has formed nine industry-defining partnerships and collaborates with players like Paradigm Spine and Centinel Spine, presenting opportunities to co-develop, co-market, or bundle technologies with aligned MSK strategies.

Data-Driven Growth VB emphasizes enhanced data to identify high-potential technologies that improve care quality and reduce costs, suggesting a selling angle for data analytics, outcomes measurement, and value-based care solutions tailored to payors and providers.